Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
about
Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients.Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
P2860
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Ex vivo pharmacodynamic study ...... arcillin plus clavulanic acid.
@en
Ex vivo pharmacodynamic study ...... arcillin plus clavulanic acid.
@nl
type
label
Ex vivo pharmacodynamic study ...... arcillin plus clavulanic acid.
@en
Ex vivo pharmacodynamic study ...... arcillin plus clavulanic acid.
@nl
prefLabel
Ex vivo pharmacodynamic study ...... arcillin plus clavulanic acid.
@en
Ex vivo pharmacodynamic study ...... arcillin plus clavulanic acid.
@nl
P2093
P2860
P356
P1476
Ex vivo pharmacodynamic study ...... arcillin plus clavulanic acid.
@en
P2093
Duchateau V
Van der Auwera P
P2860
P304
P356
10.1128/AAC.37.9.1860
P407
P577
1993-09-01T00:00:00Z